Ignite Creation Date:
2024-05-06 @ 8:10 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06282874
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-28
First Post:
2024-01-30
Brief Title:
Lorlatinib in Patients With ALK-Positive NSCLC With Brain or Leptomeningeal Metastases
Sponsor:
Guangdong Association of Clinical Trials
Organization:
Guangdong Association of Clinical Trials